Modification of some of the toxic effects of daunomycin (NSC-82,151) by pretreatment with the antineoplastic agent ICRF 159 (NSC-129,943)
- 31 March 1974
- journal article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 27 (3), 517-526
- https://doi.org/10.1016/0041-008x(74)90031-3
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Daunorubicin metabolism: estimation of daunorubicin reductaseBritish Journal of Pharmacology, 1971
- Biochemical studies on growth‐inhibitory bisdioxopiperazines. I. Effect on dna, rna and protein synthesis in mouse‐embryo fibroblastsInternational Journal of Cancer, 1970
- The Acute Pharmacological Actions of Daunomycin in the Dog and MonkeyPharmacology, 1970
- Antitumour Activity in a Series of bisDiketopiperazinesNature, 1969
- Preliminary Clinical Assessment of I.C.R.F. 159 in Acute Leukaemia and LymphosarcomaBMJ, 1969
- Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease.Clinical evaluation with special reference to childhood leukemiaCancer, 1967
- Serum Creatine Phosphokinase: A Clinical and Laboratory EvaluationAmerican Journal of Clinical Pathology, 1965
- Serum Glutamic Oxaloacetic Transaminase Activity in Human Acute Transmural Myocardial InfarctionScience, 1954